You probably know the feeling. Hands that split by the knuckles in winter, sting when you wash dishes, and never quite settle down. Most of us blame the cold and reach for more lotion.
A large new US study puts a number on it. About 9.6 percent of American adults, close to 1 in 10, live with chronic hand eczema, a persistent skin condition that moisturizer alone rarely solves.
The figures come from a study published November 11 in JAMA Dermatology. Researchers at Rosalind Franklin University of Medicine and Science surveyed 10,636 adults between March and May 2025.
The condition was more common in men (10.5 percent) than in women (8.7 percent), and in people who work, live in cities, or are under 40.
Also read: The best time to ventilate your home in winter, according to experts
Among adults in their twenties and thirties, more than 13 percent reported having it.
Three-quarters of those with the condition had symptoms that stuck around for three months or more, with two or more flare-ups in the past year. That is a very different story from the occasional bout of winter dryness.
What the condition actually looks like
Chronic hand eczema is not simply dry skin. According to the American Academy of Dermatology, the earliest sign is often dry, chapped skin that keeps coming back.
That is followed by red patches, scaling, itching, blistering, burning, and deep, painful cracks that may bleed or weep. The condition tends to get worse without treatment.
Also read: Chronic loneliness linked to 38% higher dementia risk, new study finds
The triggers are everyday. Frequent hand washing, water, soaps and detergents, cleaning chemicals, latex gloves, and cold air all push the skin barrier past what it can handle.
People who had atopic dermatitis as a child are more likely to develop it. So are nurses, hairstylists, cleaners, and anyone else whose hands stay wet for much of the day.
The first approved US treatment is only a year old
Until mid-2025 there was no drug on the US market specifically approved for moderate to severe chronic hand eczema.
In July 2025 the FDA approved Anzupgo (delgocitinib), a prescription cream from LEO Pharma that calms the immune signals driving the inflammation.
Also read: Winter is the worst time for vitamin D - and 42 percent of Americans are already low
It is cleared for adults whose eczema has not responded to prescription steroid creams or who cannot use them.
One caveat is worth flagging. The new prevalence study was funded by LEO Pharma, and several of its authors work for the company, which also sells the only approved US treatment for the condition.
For telling ordinary chapped hands apart from something more, the practical signal is time.
The American Academy of Dermatology advises seeing a dermatologist when extremely dry, painful hands do not improve with regular moisturizer.
Also read: New blood test may predict dementia risk up to 10 years before symptoms
The usual first steps are identifying the trigger, protecting the hands from water and irritants, and using a barrier repair cream. In many cases a short course of prescription cortisone cream is added before other treatments are considered.
Also read: Eating cabbage may be linked to a lower risk of certain cancers
This article is made and published by Ida-Marie Palm Varbæk, who may have used AI in the preparation.
